{
    "clinical_study": {
        "@rank": "28408", 
        "arm_group": {
            "arm_group_label": "AN24 in addition to new device (Novii)", 
            "arm_group_type": "Other", 
            "description": "FDA-cleared device (The AN24 device) used in conjunction with the new device (Novii).\nBoth devices will be placed on the patient's abdomen. Hence the patient acts as their own control."
        }, 
        "brief_summary": {
            "textblock": "This is a prospective clinical trial involving the use of the FDA-cleared Fetal ECG tracing\n      in labor with the AN24 (Fetal Monitoring device marketed by Monica Healthcare) to the Novii\n      (a newer device also created by Monica Healthcare) using the same technology with different\n      monitor placement."
        }, 
        "brief_title": "Performance Comparison of a New Fetal/Maternal Monitor With an FDA-cleared Method", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "condition": "Labor Fetal Anoxia", 
        "condition_browse": {
            "mesh_term": [
                "Anoxia", 
                "Fetal Hypoxia"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study has one arm, in which Both the FDA - Approved AN24 (Fetal Monitoring device\n      marketed by Monica Healthcare) and the new device (Novii, being investigated in this\n      clinical trial) will be placed on the patient's abdomen. After delivery of the patient's\n      infant, the data will be abstracted from the second device. This data will be compared to\n      the data from the first device for accuracy."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Term Laboring Patients\n\n        Exclusion Criteria:\n\n          -  Preterm Labor\n\n          -  Fetal Anomaly\n\n          -  Imminent cesarean"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "75", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_alias": "NCT02041949", 
            "nct_id": "NCT01889316", 
            "org_study_id": "13-0197", 
            "secondary_id": "FWA00004218"
        }, 
        "intervention": [
            {
                "arm_group_label": "AN24 in addition to new device (Novii)", 
                "description": "The Novii is a modified device with similar technology to the AN24 device already being used in the USA.", 
                "intervention_name": "Novii", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "AN24 in addition to new device (Novii)", 
                "intervention_name": "AN24", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Fetal monitoring", 
            "ECG"
        ], 
        "lastchanged_date": "February 24, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tucson", 
                    "country": "United States", 
                    "state": "Arizona", 
                    "zip": "85724"
                }, 
                "name": "University Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Performance Comparison of a New Fetal/Maternal Monitor With an FDA-cleared Method", 
        "overall_official": {
            "affiliation": "University of Arizona", 
            "last_name": "Meg Hill, MBBS", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Both the AN24 device and the Novii device will be placed on the patient's abdomen at the same time. After the patient has delivered their infant, the data from the Novii will be downloaded and checked against that from the AN24 to assess for accuracy of fetal monitoring.", 
            "measure": "Efficacy of the Novii when compared to the AN24", 
            "safety_issue": "No", 
            "time_frame": "duration of the patient's labor"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01889316"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Arizona", 
            "investigator_full_name": "Meg Hill", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of Arizona", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Arizona", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}